NASDAQ:EXAC

Exactech (EXAC) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$49.25
$49.30
50-Day Range
N/A
52-Week Range
$23.75
$50.95
Volume
255,640 shs
Average Volume
182,742 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
EXAC stock logo

About Exactech Stock (NASDAQ:EXAC)

Exactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company's segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines. The Company distributes joint replacement systems, including knee, hip, spine and extremity implant systems, and biologic products and services and bone cement materials used in orthopedic surgery and dental procedures. The Exactech Knee System provides solutions for partial, primary and revision total knee arthroplasty. Its hip solutions address the continuum of hip arthroplasty. It manufactures and distributes various products and services designed for the healing and regeneration of bone and soft tissue, including products, which contain human allograft.

EXAC Stock News Headlines

This Apple-like Innovator is Revolutionizing Healthcare
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
The Hard Truth About Investing For Retirement
Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.
Ranking SEC men's basketball coaches by win total
Chaney Johnson: A year in review
See More Headlines
Receive EXAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exactech and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/30/2017
Today
4/23/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:EXAC
CUSIP
30064E10
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • R. William Petty M.D. (Age 74)
    Executive Chairman of the Board
  • David W. Petty (Age 50)
    Chief Executive Officer, President and Director
  • Joel C. Phillips CPA (Age 49)
    Chief Financial Officer, Executive Vice President, Treasurer
  • Bruce E. Thompson (Age 59)
    Senior Vice President , General manager- Biologics and Spine Division
  • Gary J. Miller Ph.D. (Age 69)
    Executive Vice President - Research and Development
  • Donna M. Edwards (Age 44)
    Vice President, Legal and General Counsel
  • Betty A. Petty (Age 74)
    Vice President - Administration, Corporate Secretary
  • James G. Binch (Age 69)
    Independent Director
  • W. Andrew Krusen Jr. (Age 68)
    Independent Director
  • William B. Locander Ph.D. (Age 73)
    Independent Director

EXAC Stock Analysis - Frequently Asked Questions

How were Exactech's earnings last quarter?

Exactech Inc (NASDAQ:EXAC) announced its earnings results on Monday, October, 30th. The medical equipment provider reported $0.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.23 by $0.03. The medical equipment provider earned $61.40 million during the quarter, compared to analyst estimates of $61.78 million.

What other stocks do shareholders of Exactech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Exactech investors own include Immersion (IMMR), Verizon Communications (VZ), Allergan (AGN), Conformis (CFMS), Johnson & Johnson (JNJ), Zimmer Biomet (ZBH), Achieve Life Sciences (ACHV), Amgen (AMGN), Broadcom (AVGO) and Bausch Health Companies (BHC).

This page (NASDAQ:EXAC) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners